Letter to Editor in response to "Detection of endometrial cancer via molecular analysis of DNA collected with vaginal tampons" by Bakkum-Gamez et al. (Gynecol Oncol. 2015) We read with great interest the article by Bakkum-Gamez et al. "Detection of endometrial cancer via molecular analysis of DNA collected with vaginal tampons" in the recent edition of Gynecologic Oncology (Bakkum-Gamez et al., 2015) .
Several studies have demonstrated that HOXA10 is cyclically expressed in endometrial glands and stroma throughout the menstrual cycle and that aberrant expression of HOXA 10 by the epigenetic mechanism of methylation is associated with infertility and endometriosis (Taylor et al., 1998; Andersson et al., 2014; Fambrini et al., 2013a) .
Recently, our group has reported the methylation profile of HOXA10 promoter gene in EC and normal endometrial tissues obtained in different phases of menstrual cycle (Fambrini et al., 2013b) . There were statistically significant differences in mean methylation between EC and normal endometrium, suggesting a possible role of epigenetic changes in HOXA10 gene regulation in EC. This data are in agreement with other studies (Yoshida et al., 2006) indicating that HOXA 10 is aberrantly expressed in EC, and that its deregulation significantly contributes to tumor progression. Therefore, we believe that HOXA10 should be included in the panel of genes selected by the Authors to improve test performance.
Concerning DNA collection method, vaginal tampon can potentially enable self-collection and delivery to a testing laboratory by mail, extending access to EC early detection methods into setting with limited resources. However the impact of previous biopsy on tumor cell and cell-free DNA shedding in unknown and the interpretation of study is limited by collection of samples following prior endometrial instrumentation. Specimens of the study included also endometrial brushing collected via Tao brush and suspended in liquid-based solution. The median amount of DNA collected from endometrial brushing was higher respect to vaginal pool via tampon, even if both collection techniques yielded sufficient DNA quantities for methylation analysis and methylation levels between EC and BE were similar. However, an utmost relevant point is that LBEC provides the opportunity to obtain a morphological diagnosis according to accurate and standardized diagnostic criteria. Since 2003, the use of LBEC has been described by several authors in different study populations. Overall, cumulative literature on nearly four thousand patients revealed sensitivity of 78-100%, a specificity of 95-1000%, a positive predictive value (PPV) of 78-100%, and a negative predictive value (NPV) of 96-100% (Buccoliero et al., 2007 Fambrini et al., 2008 Fambrini et al., , 2012 Fambrini et al., , 2014 Kipp et al., 2008) .
We reported a very high diagnostic accuracy of LBEC in early detection of EC, even in troublesome subgroups of women such as tamoxifen users , post-menopausal subjects (Buccoliero et al., 2007) or patients with low-risk endometrial polyps . In speculating on the role of LBEC as first line investigation, we combined LBEC and transvaginal ultrasounds in women with postmenopausal bleeding observing a 100% sensitivity with 100% NPV in EC identification (Fambrini et al., 2012) .
LBEC meets most of the ideal screening test requirements such as the low rate of inadequate specimens, the reasonable cost (comparable to a liquid-based pap test), the good acceptability and the ease of execution in an office setting.
We thank Bakkum-Gamez et al. for giving the attention to early detection of EC, supporting a screening policy in high-risk population. Further studies evaluating cost-effectiveness are needed to assess the best screening modalities in developed countries. However, we believe that
